Avid Bioservices Urges Stockholders for GHO Transaction Support
Avid Bioservices, Inc. (NASDAQ: CDMO) is making waves in the financial sector with a crucial recommendation to its stockholders. The company specializes in biologics contract development and manufacturing, aiming to enhance patient lives through quality services. Recently, Avid announced that two leading independent proxy advisory firms, Institutional Shareholder Services (ISS) and Glass Lewis & Co., have advised that stockholders vote "FOR" the eagerly anticipated transaction with GHO Capital Partners LLP and Ampersand Capital Partners.
Recognition of Transaction Value
Nick Green, president and CEO of Avid Bioservices, expressed satisfaction regarding the endorsement from ISS and Glass Lewis. He noted, "We are pleased that ISS and Glass Lewis recognize the premium value of the GHO and Ampersand transaction for Avid stockholders. We encourage our stockholders to vote FOR our transaction with GHO and Ampersand today." This enthusiastic recommendation stems from a detailed evaluation of the deal's potential benefits.
Details of Advisory Recommendations
In their report, ISS highlighted several key factors justifying their recommendation. They noted that the sales process was sufficiently thorough, shareholders would receive a premium, and the implied valuation supports this premium. Moreover, the cash consideration involved assures liquidity and value for shareholders.
Voting Process Explained
Avid’s Board of Directors has unanimously recommended that stockholders participate in this significant voting process. Those interested can vote online, over the phone, or by signing and returning their proxy card. The call to action is clear: stockholders are encouraged to make their voices heard in favor of the GHO deal.
Understanding Avid Bioservices
Avid Bioservices, with over 30 years of experience, is committed to the development and CGMP manufacturing of biologics. Their extensive services cater to the unique needs of the biotechnology and biopharmaceutical sectors, from CGMP clinical and commercial drug substance manufacturing to regulatory support when needed. They thrive on providing a wide variety of process development activities, showcasing their dedication to innovation and excellence.
Commitment to Communication
For stockholders or any stakeholders with questions about this voting process, Avid Bioservices has put forth transparent communication efforts. MacKenzie Partners is on hand to provide guidance and assistance throughout this crucial time. They've made it easy to connect with them for any inquiries regarding voting or the transaction in question.
Potential Impact of the GHO and Ampersand Deal
Engaging in a partnership with GHO and Ampersand is not just a financial move; it represents a significant strategic opportunity for Avid Bioservices. The potential infusion of capital and resources could greatly enhance Avid's capability to deliver high-quality services, thereby benefiting its existing and future clients. Furthermore, the collaboration is expected to accelerate growth and innovation.
What Lies Ahead for Avid Bioservices
As Avid continues to navigate this pivotal moment, maintaining stakeholder relationships and keeping communication lines open will be vital. The outcomes of this vote could set the stage for future endeavors, allowing Avid to explore more extensive partnerships in the biologics landscape.
Frequently Asked Questions
What is the significance of the recommendations from ISS and Glass Lewis?
The recommendations indicate a favorable view of the proposed transaction, suggesting it is beneficial for stockholders based on thorough evaluation.
How are stockholders able to cast their vote?
Stockholders can vote online, by phone, or by mailing back a proxy card, ensuring various options to facilitate participation.
What services does Avid Bioservices provide?
Avid specializes in CGMP manufacturing of biologics, covering a broad range of services from process development to regulatory submissions.
Who can stockholders contact for assistance with voting?
MacKenzie Partners, Inc. is available to assist stockholders with any questions regarding the voting process or the transaction.
What are the expected outcomes of the proposed transaction?
The transaction may enhance Avid’s capabilities and accelerate growth, benefiting both the company and its stakeholders in the long term.
